The British hypothesis revisited Anthonisen N.R. Eur Respir J 2004; 23: 657-658 | |
Bigger numbers needed! Becker H.F. Eur Respir J 2004; 23: 659-660 | |
The hepatopulmonary syndrome: NO way out? Dinh-Xuan A.T., Naeije R. Eur Respir J 2004; 23: 661-662 | |
The yin and the yang of p27Kip1 as a target for cancer therapy Eymin B., Brambilla E. Eur Respir J 2004; 23: 663-664 | |
Effects of p27Kip1 on cell cycle status and viability in A549 lung adenocarcinoma cells Ishii T., Fujishiro M., Masuda M., Goshima Y., Kitamura H., Teramoto S., Matsuse T. Eur Respir J 2004; 23: 665-670 | |
Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro Kanai K., Asano K., Hisamitsu T., Suzaki H. Eur Respir J 2004; 23: 671-678 | |
Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients Decaestecker K., Decaestecker E., Castellani C., Jaspers M., Cuppens H., De Boeck K. Eur Respir J 2004; 23: 679-684 | |
Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD Banerjee D., Khair O.A., Honeybourne D. Eur Respir J 2004; 23: 685-691 | |
Inhaled corticosteroids and the risk of a first exacerbation in COPD patients de Melo M.N., Ernst P., Suissa S. Eur Respir J 2004; 23: 692-697 | |
Impact of preventing exacerbations on deterioration of health status in COPD Spencer S., Calverley P.M.A., Burge P.S., Jones P.W. Eur Respir J 2004; 23: 698-702 | |
Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters Mattson J.P., Delp M.D., Poole D.C. Eur Respir J 2004; 23: 703-707 | |
Peak or plateau maximal inspiratory mouth pressure: which is best? Windisch W., Hennings E., Sorichter S., Hamm H., Criee C.P. Eur Respir J 2004; 23: 708-713 | |
Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma Kostadima E., Tsiodras S., Alexopoulos E.I., Kaditis A.G., Mavrou I., Georgatou N., Papamichalopoulos A. Eur Respir J 2004; 23: 714-717 | |
Relationship between guideline treatment and health-related quality of life in asthma Pont L.G., van der Molen T., Denig P., van der Werf G.T., Haaijer-Ruskamp F.M. Eur Respir J 2004; 23: 718-722 | |
Asthma severity and medical resource utilisation Antonicelli L., Bucca C., Neri M., De Benedetto F., Sabbatani P., Bonifazi F., Eichler H-G., Zhang Q., Yin D.D. Eur Respir J 2004; 23: 723-729 | |
Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma Anees W., Gannon P.F., Huggins V., Pantin C.F.A., Burge P.S. Eur Respir J 2004; 23: 730-734 | |
Increased long-term mortality in heart failure due to sleep apnoea is not yet proven Roebuck T., Solin P., Kaye D.M., Bergin P., Bailey M., Naughton M.T. Eur Respir J 2004; 23: 735-740 | |
Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response Henry M.T., Inamdar L., O'Riordain D., Schweiger M., Watson J.P. Eur Respir J 2004; 23: 741-746 | |
Exercise testing in pulmonary arterial hypertension and in chronic heart failure Deboeck G., Niset G., Lamotte M., Vachiery J-L., Naeije R. Eur Respir J 2004; 23: 747-751 | |
Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats Sztrymf B., Rabiller A., Nunes H., Savale L., Lebrec D., Le Pape A., de Montpreville V., Mazmanian M., Humbert M., Herve P. Eur Respir J 2004; 23: 752-758 | |
Effect of saliva contamination on induced sputum cell counts, IL-8 and eosinophil cationic protein levels Simpson J.L., Timmins N.L., Fakes K., Talbot P.I., Gibson P.G. Eur Respir J 2004; 23: 759-762 | |
Functional residual capacity measurements in healthy infants: ultrasonic flow meter versus a mass spectrometer Pillow J.J., Ljungberg H., Hulskamp G., Stocks J. Eur Respir J 2004; 23: 763-768 | |
Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema Newell J.D., Hogg J.C., Snider G.L. Eur Respir J 2004; 23: 769-775 | |
Multidetector CT-generated virtual bronchoscopy: an illustrated review of the potential clinical indications De Wever W., Vandecaveye V., Lanciotti S., Verschakelen J.A. Eur Respir J 2004; 23: 776-782 | |
Pulmonary infiltrates in Costello Syndrome Waldburg N., Buehling F., Evert M., Burkhardt O., Welte T. Eur Respir J 2004; 23: 783-785 | |
Cough, fatigue and fever De Weerdt S., Noppen M., De Boosere E., Goossens A., Remels L., Meysman M., Pletinckx A., Vincken W. Eur Respir J 2004; 23: 786-789 | |
Amfepramone does not cause primary pulmonary hypertension Di Sacco G. Eur Respir J 2004; 23: 790 | |
From the Authors Abramowicz M., Delcroix M. Eur Respir J 2004; 23: 790-791 | |
Declaration of conflicts of interest O'Driscoll R. Eur Respir J 2004; 23: 791 | |
From the Editors Rabe K.F., Sterk P.J. Eur Respir J 2004; 23: 791 | |
Acute exacerbation of idiopathic pulmonary fibrosis Dallari R., Foglia M., Paci M., Cavazza A. Eur Respir J 2004; 23: 792 | |